Arquivamento definitivo - Art. 33 da LPI
#11.1.1
10/25/2022
RPI 2703
Application data
Number
112020021894Type
Filing
Publication
PCT
US2019029503 The application was abandoned: examination was not requested within the 36 months following the 04/26/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/25/2022. We update with every new RPI gazette, published weekly.
Applicants
BAYER HEALTHCARE LLC
US
CRISPR THERAPEUTICS AG
CH
Inventors
G. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/663,974 · 04/27/2018
US
62/773,058 · 11/29/2018
Abstract
CÉLULAS CAR-T ANTI-BCMA PARA DEPLEÇÃO DE CÉLULAS PLASMÁTICAS. A presente invenção refere-se a composições e métodos para a depleção controlada de células plasmáticas, tal como para o tratamento de várias doenças e condições associadas às células plasmáticas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
10/25/2022
RPI 2703
#11.1
08/09/2022
RPI 2692
#15.35
12/14/2021
RPI 2658
#1.3
03/09/2021
RPI 2618
#1.1
11/03/2020
RPI 2600
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.